Investigation of the cellular internalization of hydroxypropyl-beta-cyclodextrin and its effects on lysosomes
https://doi.org/10.56626/egis.v2i2.12924
Authors
View
Keywords
License
Copyright (c) 2023 Health Innovation Review
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Az Egészségügyi Innovációs Szemle folyóiratban megjelenő cikkek szabadon megoszthatók, másolhatók az anyagok bármilyen megjelenési formájában a "CC Attribution-NonCommercial-NoDerivatives 4.0" licenszben szereplő szabályok betartásával.
A cikkek változtatás nélkül terjeszthetők, és kereskedelmi felhasználásuk tilos.
How To Cite
Abstract
Cyclodextrins are widely used excipients to increase water solubility and bioavailability of lipophilic drugs. Our research group previously showed that cyclodextrins are able to enter Caco-2 intestinal epithelial cells by endocytosis, however, the cellular internalization and intracellular effects in the case of different cells have not been investigated yet. In addition, 2-hydroxypropyl-beta-cyclodextrin (HPBCD) is a potential molecule for the treatment of Niemann Pick syndrome type C due to its cholesterol complexing properties. The aim of our work is to investigate and compare the cellular internalization of HPBCD and its effect on lysosomes on Caco-2 intestinal epithelial, HeLa cervical epithelial and hCMEC/D3 brain endothelial cells.